An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients

Roche

Status: Completed

Conditions: Kidney Transplantation

Study type: Observational

Funder types: Industry

Identifiers

NCT01707550

ML25048

Details and patient eligibility

About

This observational survey study will capture all renal transplant patients in Serbia who are currently receiving CellCept (mycophenolate mofetil) as part of their immunosuppressive protocol.

Enrollment: 414 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients, >/= 18 years of age
• Recipients of renal allograft
• Patients receiving CellCept

Exclusion criteria

• N/A

Trial design

414 participants in 1 patient group

Cohort